The Swiss Venous Thromboembolism Cohort 65+

University of Lausanne Hospitals1,003 enrolled

Overview

The purpose of this prospective multicenter cohort study is to examine long-term medical outcomes, quality of life, and medical resource utilization in elderly patients (\>= 65 years) with acute venous thromboembolism (i.e., acute pulmonary embolism and/or deep vein thrombosis)

Study Type

OBSERVATIONAL

Enrollment

1,003

Conditions

Venous Thromboembolism

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Objectively confirmed acute pulmonary embolism and/or deep vein thrombosis * Age \>=65 years Exclusion Criteria: * Thrombosis at a different site than lower limb * Catheter-related thrombosis * Insufficient spoken language ability in German or French * Follow-up not possible (e.g., terminally ill patients) * Informed consent not possible (e.g., severe dementia) * Prior enrolment in the study

Locations (9)

Kantonsspital Baden

Baden, Switzerland

University Hospital of Basel

Basel, Switzerland

University Hospital of Bern

Bern, Switzerland

Kantonsspital Frauenfeld

Frauenfeld, Switzerland

Outcomes

Primary Outcomes

Venous thromboembolism recurrence

Time frame: 3-48 months

Secondary Outcomes

Overall mortality

Time frame: 3-48 months

Major bleeding

Time frame: 3-48 months

Post-thrombotic syndrome

Time frame: 3-48 months

Generic and disease-specific health-related quality of life

Time frame: 3-48 months

Medical resource utilization

Time frame: 3-48 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.